# The Pharmacodynamics of Doripenem Between 4-hour and 1-hour Infusion in Patients With Ventilator-associated Pneumonia

> **NCT01467648** · PHASE4 · COMPLETED · sponsor: **Sutep Jaruratanasirikul** · enrollment: 12 (actual)

## Conditions studied

- Ventilator-Associated Pneumonia

## Interventions

- **DRUG:** Doripenem
- **DRUG:** Doripenem

## Key facts

- **NCT ID:** NCT01467648
- **Lead sponsor:** Sutep Jaruratanasirikul
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2011-11-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01467648

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01467648, "The Pharmacodynamics of Doripenem Between 4-hour and 1-hour Infusion in Patients With Ventilator-associated Pneumonia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01467648. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*